| Financial Year |
March 31 2023 |
| Monetary Funds |
9,981,077,691.02 |
| Held-for-trading Financial Assets |
257,137,565.16 |
| Notes Receivable |
58,754,664.86 |
| Accounts Receivable |
8,014,731,951.16 |
| Advances to Suppliers |
71,651,308.90 |
| Other Receivables |
105,004,441.80 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
9,970,519,228.25 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
282,400.62 |
| Other Current Assets |
755,889,111.16 |
| Total Current Assets |
29,215,048,362.93 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
12,534,917.72 |
| Long-term Equity Investment |
492,647,519.17 |
| Investment Properties |
-- |
| Fixed Assetes |
4,430,544,035.73 |
| Under-construction Projects |
375,232,940.70 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
404,339,947.05 |
| R&D expenses |
-- |
| Goodwill |
579,636,409.84 |
| Long-Term Deferred and Prepaid Expenses |
173,634,472.07 |
| Deferred Income Tax Assets |
361,464,450.51 |
| Other Non-Current Assets |
140,348,605.31 |
| Sub-Total of Non-Current Assets |
7,657,101,774.12 |
| Total Assets |
36,872,150,137.05 |
| Short-Term Loans |
4,542,624,365.57 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
9,189,953,700.49 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
1,001,141,685.93 |
| Taxes Payable |
356,917,199.46 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
719,715,662.06 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
508,607,015.18 |
| Other Current Liabilities |
1,161,638.00 |
| Sub-Total of Current Liabilities |
16,804,776,212.82 |
| Long-term Loans |
56,047,303.13 |
| Bonds Payable |
3,274,457,663.72 |
| Long-Term Accounts Payable |
24,662,620.43 |
| Special Payable |
-- |
| Estimatied Liabilities |
6,666,284.55 |
| Deferred Income Tax Liabilities |
84,963,272.90 |
| Other Non-Current Liabilities |
3,216,284.01 |
| Sub-Total of Non-Current Liabilities |
4,067,190,839.64 |
| Total Liabilities |
20,871,967,052.46 |
| Paid-In Capital(Or Share Stock) |
2,207,147,357.00 |
| Capital Surplus |
2,239,232,118.73 |
| Surplus Reserve |
862,080,832.26 |
| LESS:Treasury Stock |
327,082,476.93 |
| Undistributed Profits |
10,553,030,003.03 |
| Minority Stockholder's Interest |
458,105.54 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
15,999,724,979.05 |
| Owner's Equity（Stockholder's Equity） |
16,000,183,084.59 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
36,872,150,137.05 |
